Thrombophilia

Published on 03/04/2015 by admin

Filed under Hematology, Oncology and Palliative Medicine

Last modified 03/04/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1454 times

39

Thrombophilia

Patients who are predisposed to thrombosis generally either have a disorder of the blood or an abnormality of the vessel wall. Where enhanced coagulation is the major mechanism, the disorder is referred to as ‘thrombophilia’. Patients with thrombophilia either tend to have thrombosis at an unusually early age or to develop recurrent thrombotic problems. Venous thrombosis predominates with the chance of thrombosis increased by the coexistence of other risk factors. Thrombophilia can be inherited or acquired.

Which patients should be investigated for thrombophilia?

Testing for heritable thrombophilia is not indicted in unselected patients presenting with venous thrombosis. Table 39.1 summarises factors which should prompt consideration of thrombophilia. Accurate history taking is essential; particular attention should be given to the nature of the recent thrombotic event, the presence of known risk factors (Table 39.2), a previous history of thrombosis and the family history. Definition of a ‘positive’ family history of thrombosis is problematic. If we use the simple definition of a history of deep vein thrombosis (DVT) or pulmonary embolus (PE) in a first or second degree relative, then approximately 25% of all patients will have a positive family history. Even among those with a strong family history only a small minority will have a cause of inherited thrombophilia identified.

Table 39.2

Major risk factors for thrombosis

Venous Arterial
Increasing age Increasing age
Immobility Smoking
Obesity Male sex
Oral contraceptive pill Hypertension
Trauma/surgery Strong family history
Thrombophilia (see text) Hyperlipidaemia
Pregnancy Diabetes mellitus
Malignancy Raised fibrinogen

Basic investigations of thrombophilia should include a blood count (to exclude polycythaemia and other myeloproliferative disorders) and a coagulation screen. Further laboratory testing is dictated by the possible causes of familial and acquired thrombophilia detailed below. Testing for thrombophilia should not be undertaken during an acute episode of venous thromboembolism when low levels of coagulation inhibitors are routinely found. Systemic disorders such as liver disease or disseminated intravascular coagulation (DIC) can depress the levels of coagulation inhibitors and thus simulate the laboratory abnormalities found in familial thrombophilia.

Familial thrombophilia

Buy Membership for Hematology, Oncology and Palliative Medicine Category to continue reading. Learn more here